Abstract:Human uveal melanoma is the most common primary intraocular tumor, and brachytherapy is one of the most common and effective treatment strategies. In order to find a safer and more effective way to increase the radio sensitivity of the tumor, we tried to use the dendrimer nanoparticle performing coexpression gene radiotherapy. In this study, we constructed recombinant DNA plasmids (early growth response-1 tumor necrosis factor-α [pEgr1-TNFα], pEgr1 thymidine kinase [TK], and pEgr1-TNFα-TK) according to the Egr1 promoter sequence. The sequences of human TNFα and herpes simplex virus (HSV) TK that were published by GenBank. Agarose gel electrophoresis and DNA sequencing had proven that we constructed the double-gene recombined plasmids pEgr1-TNF-TK correctly, as well as the plasmids pEgr1-TNFα and pEgr1-TK. The dendrimer nanoparticles combined with plasmid DNA as dendriplexes were verified with agarose gel electrophoresis and observed by transmission electron microscopy (TEM) and scanning electron microscopy to define size and shape. Zeta potential was measured using a Zetasizer analyzer. Optimal size and neutral zeta-potential characteristics of dendriplexes were achieved for the transfection studies. DNase I examination proved that the dendriplexes could protect plasmid DNA for at least 6 hours. The recombinant plasmids were transfected with dendrimer nanoparticles into the human choroidal melanoma OCM-1 cell line, followed by exposure to iodine-125 ((125)I) after transfection. After transfection with dendrimer nanoparticles and the irradiation of (125)I, the gene expressions of TNFα and HSV1-TK were significantly increased at the protein level by enzyme-linked immunosorbent assay and Western blot analysis in OCM-1 cells. The cellular morphology of OCM-1 cells altering was observed by TEM, and a decrease in cell proliferation was revealed in cell-growth curves. Flow cytometry of annexin V/propidium iodide double-dyeing apoptosis and caspase-3 fluorescence staining showed that this treatment method could turn transfected OCM-1 cells into apoptosis and necrosis by the effects of the gene expression. This study indicated that the dendrimer nanoparticles with coexpression of TNF-α and HSV1-TK gene therapy are effective and safe and can provide us with a novel strategy to treat human uveal melanoma in the future.

Viral Therapy Using the Oncolytic Adenovirus H101 to Treat Uveal Melanoma

Recombinant Oncolytic Adenovirus H101 Combined with Sibcl2: Cytotoxic Effect on Uveal Melanoma Cell Lines

Combination of oncolytic adenovirus and dacarbazine enhances antitumor ability against uveal melanoma cells via cell cycle block

The Oncolytic Virus H101 Combined with GNAQ Sirna-Mediated Knockdown Reduces Uveal Melanoma Cell Viability

Therapeutic efficacy by targeting correction of Notch1-induced aberrants in uveal tumors.

Oncolytic adenovirus H101 enhanced antitumor effects of PD-1 blockade by downregulating CD47 on tumor cells

Anti- Tumor Effect of a Replication-Selective Oncolytic Adenovirus (H101) on Mice Bearing B16 Melanoma

The antitumor effects of oncolytic adenovirus H101 against lung cancer

[Phase II Clinical Study of Intratumoral H101, an E1B Deleted Adenovirus, in Combination with Chemotherapy in Patients with Cancer].

Recombinant human adenovirus type 5 promotes anti-tumor immunity via inducing pyroptosis in tumor endothelial cells

Intra-tumor Injection of H101, a Recombinant Adenovirus, in Combination with Chemotherapy in Patients with Advanced Cancers: a Pilot Phase II Clinical Trial.

Inhibition of Retinoblastoma in Vitro and in Vivo with Conditionally Replicating Oncolytic Adenovirus H101

Antitumor Efficacy of Oncolytic Herpes Virus Type 1 Armed with GM-CSF in Murine Uveal Melanoma Xenografts

Effects of Oncogenic Gαq and Gα11 Inhibition by FR900359 in Uveal Melanoma

Macrophage polarization contributes to the efficacy of an oncolytic HSV-1 targeting human uveal melanoma in a murine xenograft model

Assessment of a Capsid-Modified E1B 55-Kda Protein-Deficient Adenovirus Vector for Tumor Treatment

Oncolytic Adenovirus H101 Synergizes With Radiation In Cervical Cancer Cells

Intraperitoneal Oncolytic Virotherapy for Patients with Malignant Ascites: Characterization of Clinical Efficacy and Antitumor Immune Response

Efficacy and safety of dendrimer nanoparticles with coexpression of tumor necrosis factor-α and herpes simplex virus thymidine kinase in gene radiotherapy of the human uveal melanoma OCM-1 cell line

RESEARCH ON DISSEMINATION OF RECOMBINANT ADENOVIRUS INTRA-TUMOR INJECTION IN HUMAN BODY

Antitumor efficacy of oncolytic HSV-1 expressing cytosine deaminase is synergistically enhanced by DPD down-regulation and EMT inhibition in uveal melanoma xenograft